Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen Deprivation Therapy: Post Hoc Analysis of Phase 3 LATITUDE Study

Matsubara, Nobuaki; Chi, Kim; ÖZGÜROĞLU, Mustafa; Rodriguez-Antolin, Alfredo; Feyerabend, Susan; Fein, Luis; Alekseev, Boris; Sulur, Giri; Protheroe, Andrew; Li, Susan; Mundle, Suneel; De Porre, Peter; Tran, Namphuong; Fizazi, Karim

doi:10.1016/j.eururo.2019.11.021

Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen Deprivation Therapy: Post Hoc Analysis of Phase 3 LATITUDE Study

Matsubara N., Chi K. N., ÖZGÜROĞLU M., Rodriguez-Antolin A., Feyerabend S., Fein L., ...Daha Fazla

EUROPEAN UROLOGY, cilt.77, sa.4, ss.494-500, 2020 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 77 Sayı: 4
Basım Tarihi: 2020
Doi Numarası: 10.1016/j.eururo.2019.11.021
Dergi Adı: EUROPEAN UROLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, BIOSIS, EMBASE, Gender Studies Database, MEDLINE
Sayfa Sayıları: ss.494-500
İstanbul Üniversitesi Adresli: Hayır

Özet

Background: LATITUDE, a randomized, double-blind trial, compared abiraterone acetate and prednisone (AAP) + androgen deprivation therapy (ADT) versus placebo (PBO) + ADT in high-risk metastatic castration-sensitive prostate cancer (mCSPC).